Paper4570848
Actions of aurintricarboxylate, kasugamycin, and pactamycin on Escherichia coli polysomes.
Tai PC and 2 others. Biochemistry, 1973. Cited by 47 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Actions of aurintricarboxylate, kasugamycin, and pactamycin on Escherichia coli polysomes. Papers, record 4570848. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4570848
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Actions of aurintricarboxylate, kasugamycin, and pactamycin on Escherichia coli polysomes.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Antibiotics, Antineoplastic | Major topic |
| Cyclohexanecarboxylic Acids | Major topic |
| Escherichia coli | Major topic |
| Polyribosomes | Major topic |
| Amino Acids | |
| Amino Sugars | |
| Bacterial Proteins | |
| Benzoates | |
| Carbon Isotopes | |
| Centrifugation, Density Gradient | |
| Chromatography, Gel | |
| Inositol | |
| Magnesium | |
| Peptide Biosynthesis | |
| Peptide Chain Elongation, Translational | |
| Peptide Chain Initiation, Translational | |
| Phenols | |
| Sucrose | |
| Valine |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30,447,062 | Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation. | EcoSal Plus | 2018 | https://conductscience.org/library/papers/30447062 | PubMed |
| 25,250,841 | Time-dependent effects of transcription- and translation-halting drugs on the spatial distributions of the Escherichia coli chromosome and ribosomes. | Mol Microbiol | 2014 | https://conductscience.org/library/papers/25250841 | PubMed |
| 16,998,486 | Structural analysis of kasugamycin inhibition of translation. | Nat Struct Mol Biol | 2006 | https://conductscience.org/library/papers/16998486 | PubMed |
| 8,226,693 | Resistance of lambda cI translation to antibiotics that inhibit translation initiation. | J Bacteriol | 1993 | https://conductscience.org/library/papers/8226693 | PubMed |
| 6,901,544 | Ribosomal function and its inhibition by antibiotics in prokaryotes. | Naturwissenschaften | 1980 | https://conductscience.org/library/papers/6901544 | PubMed |
| 6,801,425 | Conditional lethal mutants of Bacillus subtilis dependent on kasugamycin for growth. | Mol Gen Genet | 1981 | https://conductscience.org/library/papers/6801425 | PubMed |
| 6,337,124 | Escherichia coli kasugamycin dependence arising from mutation at the rpsI locus. | J Bacteriol | 1983 | https://conductscience.org/library/papers/6337124 | PubMed |
| 4,598,299 | The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites. | Proc Natl Acad Sci U S A | 1974 | https://conductscience.org/library/papers/4598299 | PubMed |
| 4,577,795 | Partial inhibition of polysomal ribosomes of Escherichia coli by streptomycin. | Proc Natl Acad Sci U S A | 1973 | https://conductscience.org/library/papers/4577795 | PubMed |
| 1,915,283 | Interaction of antibiotics with A- and P-site-specific bases in 16S ribosomal RNA. | EMBO J | 1991 | https://conductscience.org/library/papers/1915283 | PubMed |
| 1,691,097 | The IS10 antisense RNA blocks ribosome binding at the transposase translation initiation site. | EMBO J | 1990 | https://conductscience.org/library/papers/1691097 | PubMed |
| 1,653,948 | Lack of a 5' non-coding region in Tn1721 encoded tetR mRNA is associated with a low efficiency of translation and a short half-life in Escherichia coli. | Nucleic Acids Res | 1991 | https://conductscience.org/library/papers/1653948 | PubMed |
| 1,372,890 | The Tn10-encoded tetracycline resistance mRNA contains a translational silencer in the 5' nontranslated region. | J Bacteriol | 1992 | https://conductscience.org/library/papers/1372890 | PubMed |
| 1,190,754 | Inhibition of protein synthesis in intact HeLa cells. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/1190754 | PubMed |
| 1,096,807 | Effect of tetracycline on puromycin-induced polysome degradation: influence of magnesium and polyamines. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/1096807 | PubMed |
| 818,501 | Selective messenger translation by Bacillus subtilis ribosomes. | Mol Gen Genet | 1976 | https://conductscience.org/library/papers/818501 | PubMed |
| 363,701 | Kasugamycin-dependent mutants of Escherichia coli. | J Bacteriol | 1978 | https://conductscience.org/library/papers/363701 | PubMed |
| 349,350 | Translation and mRNA decay. | Mol Gen Genet | 1978 | https://conductscience.org/library/papers/349350 | PubMed |
| 347,402 | Studies on ribosome structure and interactions near the m62Am62A sequence. | Nucleic Acids Res | 1978 | https://conductscience.org/library/papers/347402 | PubMed |
| 94,160 | Intermolecular base-paired interaction between complementary sequences present near the 3' ends of 5S rRNA and 18S (16S) rRNA might be involved in the reversible association of ribosomal subunits. | Nucleic Acids Res | 1979 | https://conductscience.org/library/papers/94160 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4570848
GET https://conductscience.org/api/papers/v1/4570848/authors